Application of an opioid use disorder cascade of care in a large public health system

References

• Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800. doi:10.1093/cid/ciq243.
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Engineering, and Medicine. Medications for opioid use disorder save lives. Washington (DC): The National Academies Press; 2019.
   Google Scholar
• Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, Chen A, Tran LT, Bharat C, Padmanathan P, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiarty. 2021;78:979–993. doi:10.1001/jamapsychiatry.2021.0976. Cited in: PMID: 34076676.
   PubMed Web of Science ®Google Scholar
• Upadhyaya A, Marks LR, Schwarz ES, Liang SY, Durkin MJ, Liss DB. Care cascade for patients with opioid use disorder and serious injection related infections. Toxicol Commun. 2021;5:6–10. doi:10.1080/24734306.2020.1869899.
   PubMed Web of Science ®Google Scholar
• Yedinak JL, Goedel WC, Paull K, Lebeau R, Krieger MS, Thompson C, Buchanan AL, Coderre T, Boss R, Rich JD, et al. Defining a recovery-oriented cascade of care for opioid use disorder: a community-driven, statewide cross-sectional assessment. PLoS Med. 2019;16:e1002963. doi:10.1371/journal.pmed.1002963.
   PubMed Web of Science ®Google Scholar
• Prieto JT, McEwen D, Davidson AJ, Al-Tayyib A, Gawenus L, Sangareddy SRP, Blum J, Foldy S, Shlay JC. Monitoring opioid addiction and treatment: do you know if your population is engaged? Drug Alcohol Depend. 2019;202:65–60. doi:10.1016/j.drugalcdep.2019.07.002.
   Web of Science ®Google Scholar
• Williams AR, Johnson KA, Thomas CP, Reif S, Socías ME, Henry BF, Neighbors C, Gordon AJ, Horgan C, Nosyk B, et al. Commentary article: opioid use disorder cascade of care framework design: a roadmap. Subst Abus. 2022;43:1207–1214.
   PubMed Web of Science ®Google Scholar
• Williams AR, Nunes EV, Olfson M To battle the opioid overdose epidemic deploy the ‘cascade of care’ model. Health Affairs Blog; 2017 Mar 13 [accessed 2023 May 15]. doi:10.1377/hblog20170313.059163.
   Google Scholar
• Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin F, et al. Developing an opioid use disorder treatment cascade: a review of quality measures. J Subst Abuse Treat. 2018;91:57–68. doi:10.1016/j.jsat.2018.06.001. Cited in: PMID: 29910015.
   PubMed Web of Science ®Google Scholar
• Williams AR, Nunes EV, Bisaga A, Levin F, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019;45:1–10. doi:10.1080/00952990.2018.1546862.
   PubMed Web of Science ®Google Scholar
• Haber N, Pillay D, Porter K, Barnighausen T. Constructing the cascade of HIV care: methods for measurement. Curr Opin HIV AIDS. 2016;11:102–108. doi:10.1097/COH.0000000000000212. Cited in: PMID: 26545266.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Publishing; 2013.
   Google Scholar
• Marsden J, Tai B, Ali R, Hu L, Rush AJ, Volkow N. Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective? Addiction. 2019;114:1346–1353. doi:10.1111/add.14546. Cited in: PMID: 30614096.
   PubMed Web of Science ®Google Scholar
• Khalid L, Cunningham C, Deng Y, Masyukova M, Bumol J, Valle A, Zhang C, Lu T. Cascade of care for office-based buprenorphine treatment in Bronx community clinics. J Subst Abuse Treat. 2022;139:108778. doi:10.1016/j.jsat.2022.108778. Cited in: PMID: 35428524.
   PubMed Web of Science ®Google Scholar
• NYC Health + Hospitals. Community health needs assessment: 2019. New York (NY): 2019 Jun 30 [accessed 2023 May 15]. https://hhinternet.blob.core.windows.net/uploads/2019/08/chna-2019.pdf
   Google Scholar
• Lynch K New York City Council oversight hearing: electronic health records. NYC Health + Hospitals; 2019 Nov 20 [accessed 2022 Nov 22]. https://www.nychealthandhospitals.org/new-york-city-council-oversight-hearing-electronic-health-records/.
   Google Scholar
• Kelecheva B The SQL standard – ISO/IEC 9075: 2016 (ANSI X3.135). American National Standards Institute Blog; 2018, Oct 5 [accessed 2023 May 15]. https://blog.ansi.org/2018/10/sql-standard-iso-iec-9075-2016-ansi-x3-135/.
   Google Scholar
• Hagman BT, Falk D, Litten R, Koob GF. Defining recovery from alcohol use disorder: development of an NIAAA research definition. Am J Psychiatry. 2022;179:807–813. doi:10.1176/appi.ajp.21090963.
   PubMed Web of Science ®Google Scholar
• McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, Weinstein ZM, Billings J, Davis NJ, Marcello RK, et al. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment. Addict Sci Clin Pract. 2019;14:5. doi:10.1186/s13722-019-0135-7.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Use of pharmacotherapy for opioid use disorder (OUD) (NQF 3400): technical specifications and resource manual. 2019 Apr [accessed 2023 May 15]. https://www.medicaid.gov/state-resource-center/innovation-accelerator-program/iap-downloads/functional-areas/techspecsmanual-nqf-3400.pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Medications for opioid use disorder: for healthcare and addiction professionals, policymakers, patients, and families. 2021. Treatment Improvement Protocol 63; [accessed 2023 May 15]. https://store.samhsa.gov/sites/default/files/pep21-02-01-002.pdf.
   Google Scholar
• Krawczyk N, Feder KA, Fingerhood MI, Saloner B. Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. Drug Alcohol Depend. 2017;178:512–18. doi:10.1016/j.drugalcdep.2017.06.009. Cited in: PMID: 28719885.
   PubMed Web of Science ®Google Scholar
• HEDIS®. Technical specifications for health plans. Washington (DC): National Committee for Quality Assurance; 2021.
   Google Scholar
• National Committee for Quality Assurance. Proposed changes to existing measure for HEDIS®1 MY 2022: initiation and engagement of alcohol and other drug abuse or dependence treatment (IET). 2021 [accessed 2023 May 15]. https://www.ncqa.org/wp-content/uploads/2021/02/11.-IET.pdf.
   Google Scholar
• Williams AR, Mauro CM, Feng T, Wilson A, Cruz A, Olfson M, Crystal S, Samples H, Chiodo L. Performance measurement for medication for opioid use disorder and retention in care. Am J Psychiatry. 2023;180:454–57. doi:10.1176/appi.ajp.20220456.
   PubMed Web of Science ®Google Scholar
• Au-Yeung CM, Blewett LA, Winkelman T. Increasing access to medications for opioid use disorder: policy strategies during and after COVID-19 pandemic. New York (NY): Millbank Memorial Fund; 2021 Oct [accessed 2023 May 15]. https://www.milbank.org/wp-content/uploads/2021/10/Au-Yeung_Brief_5.pdf.
   Google Scholar
• National Quality Forum. Behavioral health 2016-2017: technical report. Washington (DC): 2017 Aug 28 [accessed 2023 May 15]. https://www.qualityforum.org/Publications/2017/08/Behavioral_Health_2016-2017_Final_Report.aspx.
   Google Scholar
• Dong H, Stringfellow EJ, Russell WA, Bearnot B, Jalali MS. Impact of alternative ways to operationalize buprenorphine treatment duration on understanding continuity of care for opioid use disorder. Int J Ment Health Addiction. 2022. doi:10.1007/s11469-022-00985-w.
   Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Opioid treatment program (OTP) guidance. Rockville (MD): 2020 Mar 19 [accessed 2023 May 15]. https://www.samhsa.gov/sites/default/files/otp-guidance-20200316.pdf.
   Google Scholar
• Chang JE, Franz B, Cronin CE, Lindenfeld Z, Lai AY, Pagán JA. Racial/Ethnic disparities in the availability of hospital based opioid use disorder treatment. J Subst Abuse Treat. 2022;138:108719. doi:10.1016/j.jsat.2022.108719.
   PubMed Web of Science ®Google Scholar
• Adams JM, Volkow ND. Ethical imperatives to overcome stigma against people with substance use disorders. AMA J Ethics. 2020;22:E702–708. doi:10.1001/amajethics.2020.702.
   PubMedGoogle Scholar
• Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Montague HDG. “You’re not supposed to be on it forever”: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Subst Abuse. 2022;16:11782218221103859. doi:10.1177/11782218221103859. Cited in: PMID: 35783464.
   Web of Science ®Google Scholar
• Skinner HA. The drug abuse screening test. Addict Behav. 1982;7:363–371. doi:10.1016/0306-4603(82)90005-3. Cited in: PMID: 7183189.
   PubMed Web of Science ®Google Scholar
• Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the drug abuse screening test. J Subst Abuse Treatment. 2007;32:189–98. doi: 10.1016/j.jsat.2006.08.002. Cited in: PMID: 17306727.
   PubMed Web of Science ®Google Scholar
• Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94:135–40. Cited in: PMID: 7778330.
   PubMedGoogle Scholar
• Banta-Green CJ, Hansen RN, Ossiander EM, Wasserman CR, Merrill JO. Buprenorphine utilization among all Washington state residents’ based upon prescription monitoring program data – characteristics associated with two measures of retention and patterns of care over time. J Substance Abuse Treat. 2021;127:108446. doi:10.1016/j.jsat.2021.108446.
   PubMed Web of Science ®Google Scholar
• Krawczyk N, Mojtabai R, Stuart EA, Fingerhood M, Agus D, Lyons BC, Weiner JP. Saloner B opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services. Addiction. 2020;115:1683–94. doi:10.1111/add.14991.
   PubMed Web of Science ®Google Scholar